Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be ...

Insulet Corporation (NASDAQ: PODD) is one of the best NASDAQ stocks with high upside potential. On June 6, Insulet announced ...

Findings from the STRIVE study indicated improved glycaemic control with Omnipod 6 compared to Omnipod 5.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced new clinical results ...

Insulet (PODD) has been back in focus after new clinical data on its investigational Omnipod 6 and fully closed loop system, ...

Insulet has begun shipping Omnipod 5 pods with the new algorithm to US retailers ahead of a broader software update.

ORLANDO -- The novel Omnipod and Diabeloop closed-loop systems looked safe and more effective than conventional management of type 1 diabetes in trial programs with increasingly real-world scenarios, ...

STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across age groups and diabetes types EVOLUTION 3 feasibility study demonstrates improved time in range using ...